Rankings
▼
Calendar
COLL FY 2023 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
FY 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$567M
+22.2% YoY
Gross Profit
$326M
57.5% margin
Operating Income
$167M
29.5% margin
Net Income
$48M
8.5% margin
EPS (Diluted)
$1.29
Cash Flow
Operating Cash Flow
$275M
Free Cash Flow
$274M
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$948M
Stockholders' Equity
$195M
Cash & Equivalents
$239M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$567M
$464M
+22.2%
Gross Profit
$326M
$209M
+55.7%
Operating Income
$167M
$33M
+401.1%
Net Income
$48M
-$25M
+292.6%
← Q4 2022
All Quarters
Q1 2023 →